Gossamer Bio GOSS
NASDAQ GOSS
$0.16 +0.00 (+1.52%)
As of: Aug 21, 2026 · 2:23 PM EDT

Gossamer Bio (GOSS) Short term Debt (2022 - 2026)

Gossamer Bio (GOSS) posted quarterly Short term Debt of $9.6 million for Q1 2024, down 17.43% year-over-year from $11.6 million in Q2 2023, and down 17.43% quarter-over-quarter from $11.6 million in Q4 2023.

Gossamer Bio (GOSS) Short term Debt (2022 - 2026) Analysis & Trends

Gossamer Bio's Short term Debt history runs 3 years deep, the most recent figure standing at $9.6 million for Q1 2024.

  • In Q1 2024, Short term Debt fell 17.43% year-over-year to $9.6 million; the TTM figure through Mar 2024 stood at $9.6 million (down 17.43% YoY), while the FY2023 annual figure was $11.6 million, changed 0.0% from the prior year.
  • Short term Debt for Q1 2024 stood at $9.6 million, down from $11.6 million in the prior quarter.
  • The five-year high for Short term Debt was $11.6 million in Q4 2022, with the low at $9.6 million in Q1 2024.
  • The 3-year median for Short term Debt is $11.6 million (2022), against an average of $11.3 million.
  • The sharpest annual moves came in 2023 and 2024: Short term Debt changed 0.0% in 2023, then retreated 17.43% in 2024.
  • Gossamer Bio's Short term Debt stood at $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then decreased by 17.43% to $9.6 million in 2024.
  • Business Quant data shows GOSS's Short term Debt at $9.6 million in Q1 2024, $11.6 million in Q4 2023, and $11.6 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.89 Bn 131.04 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.05 Bn 78.06 Bn 3.93 Bn
3 Argenx Se 65.56 Bn 60.38 Bn 1.37 Bn
4 Moderna 55.46 Bn 50.32 Bn 52.00 Mn
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 27.70 Bn 9.30 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.38 Bn 26.54 Bn -
10 Gossamer Bio 51.17 Mn -5.86 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 36.15 Mn
Mar 31, 2024 9.59 Mn
Dec 31, 2023 11.61 Mn
Sep 30, 2023 11.61 Mn
Jun 30, 2023 11.61 Mn
Mar 31, 2023 11.61 Mn
Dec 31, 2022 11.61 Mn